OVERVIEW

Optimizing Glycemic Control: A Continuing Quality Improvement Program For Primary Care is organized by RealCME and will be held from Jul 10, 2018 - Jul 10, 2019.

Target Audience:
This activity has been designed to meet the educational needs of primary care clinicians, nurse practitioners (NPs), physician assistants (PAs) and other health care professionals involved in the care of patients with diabetes.

Accreditation:
Horizon CME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Objectives:
After completing this activity, the participant will demonstrate the ability to:
• Outline the benefits, indications, and role of continuous glucose monitoring (CGM) in optimizing glycemic control in patients with T2DM
• Describe the clinical and pharmacokinetic/pharmacodynamic (PK/PD) differences between ultralong-acting and conventional basal insulins
• Incorporate newer basal insulins to optimize diabetes therapy and achieve A1C goals

Additional details will be posted as soon as they are available.